P11.65.B GBM AGILE: A Global, Phase 2/3 Adaptive Platform Trial to Evaluate Multiple Treatment Regimens in Newly Diagnosed and Recurrent Glioblastoma
Neuro-Oncology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined